GMMMG logo

NHS photos

NHS logo

News Summary

From this page you will be able to access a summary of additions or changes to the GMMMG website on a monthly basis

July 2018 

 

High Cost Drugs Subgroup (HCDSG)

19.7.18

Following a chair’s action, guselkumab for the treatment of moderate to severe plaque psoriasis has been added to formulary, in accordance with NICE TA521, with immediate effect. It is intended that guselkumab will be positioned in the same place in therapy as secukinumab and ixekizumab. The formulary and RAG list will be updated to reflect this change.

Formulary and Managed Entry Subgroup (FMESG)

19.7.18

The paediatric RAG list has been updated to reflect the new format adopted for the adult RAG/DNP/grey list. This new format allows users to sort drugs by:

  • RAG status
  • Formulary status
  • BNF chapter
  • Date added

To view the newly updated list, click here

19.7.18

Following GM-wide consultation and approval by GMMMG, actions from the May meeting of FMESG have been added to the formulary and RAG/DNP/Grey list:

  • Brodalumab for moderate to severe plaque psoriasis was added to formulary as a RED drug
  • Lurasidone for treatment of schizophrenia was added to the Grey list, to be used in adults who  meet the specified criteria
  • Cariprazine and dicycloverine were added to the DNP list, on the basis that more cost-effective options are available
  • Links to new NICE guidance and MHRA Drug Safety Updates were added to formulary
  • All formulary chapters were amended to update links to the new combined RAG/DNP/Grey list

Pathways and Guidelines Development Subgroup (PaGDSG)

23.7.18

On behalf of the GMMMG Pathways and Guidelines Development Subgroup, a Greater Manchester-wide Shared Care Protocol for Apomorphine use in Parkinson’s Disease is in development. We now seek the comments of all GM NHS healthcare professionals on this draft. This consultation period is open until 5pm on Monday 20th August 2018.

12.7.18

On behalf of the GMMMG Pathways and Guidelines Development Subgroup, a Greater Manchester-wide Shared Care Protocol for Azathioprine for Interstitial Lung Disease is in development. We now seek the comments of all GM NHS healthcare professionals on this draft. This consultation period is open until 5pm Thursday 9th August 2018.

9.7.18

On behalf of the GMMMG Pathways and Guidelines Development Subgroup, a Greater Manchester-wide Shared Care Protocol for Oral Methotrexate for IBD is in development. We now seek the comments of all GM NHS healthcare professionals on this draft. This consultation period is open until 5pm on 6th August 2018.

9.7.18

On behalf of the GMMMG Pathways and Guidelines Development Subgroup, a Greater Manchester-wide Shared Care Protocol for Goserelin in Breast Cancer is in development. We now seek the comments of all GM NHS healthcare professionals on this draft. This consultation period is open until 5pm Monday 6th August 2018.

GMMMG

5.7.18

The GMMMG RAG, DNP & Grey lists have been moved to a single page, for ease of use. This new combined format allows users to sort drugs by:

  • RAG status
  • Formulary status
  • BNF chapter
  • Date added

To view the newly updated list, click here

<< Back

Line

TERMS AND CONDITIONS    |    CONTACT US    |    ABOUT US    |    ARCHIVE

RSS Feed
 
spacer